论文部分内容阅读
目的:观察生长激素在宫腔粘连分离术后预防粘连中的临床应用价值。方法:选取我院2009年12月-2013年12月期间收治的100例行宫腔粘连分离术的患者,按每组50例随机分为A、B两组。给予A组患者放置宫内节育器联合药物治疗,B组患者在其治疗基础之上,给予生长激素治疗,对比两组患者临床治疗效果。结果:A组患者再粘连率为46.0%,月经恢复有效率为82.0%;B组患者再粘连率为28.0%,月经恢复有效率为94.0%。两组患者粘连率对比,有显著性差异(P<0.05)。结论:生长激素可有效预防宫腔粘连分离术后粘连的再次发生,效果显著,值得临床推广与应用。
Objective: To observe the clinical value of growth hormone in the prevention of adhesion after intrauterine adhesions. Methods: A total of 100 patients undergoing hysterosalpingography in our hospital from December 2009 to December 2013 were randomly divided into two groups (A and B). Patients in group A were given IUD combined with drug treatment. Patients in group B were given growth hormone treatment on the basis of their treatment, and the clinical treatment effect was compared between the two groups. RESULTS: In group A, the rate of re-adhesion was 46.0% and the effective rate of menstruation was 82.0%. In group B, the rate of re-adhesion was 28.0% and the rate of menstruation recovery was 94.0%. There was significant difference between the two groups in the adhesion rate (P <0.05). Conclusion: GH can effectively prevent the recurrence of adhesions after intrauterine adhesions, the effect is significant, worthy of clinical promotion and application.